BAFNAPHARM
- Series
- EQ
- F&O
- No
- Status
- Inactive since 02 Apr 2019
Source: NSE equity master · as of 01 Apr 2019
- 13 Feb 2020 19:58PDF · -Results
Bafna Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended December 31, 2019.
- 13 Nov 2019 17:54PDF · -Results
Bafna Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended September 30, 2019.
- 27 Aug 2019 14:41PDF · -Results
The Exchange had sought clarification from Bafna Pharmaceuticals Limited for the quarter ended 30-Jun-2019 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: -1. Financial results submitted is not as per format prescribed by SEBI The response of the Company is enclosed.
- 14 Aug 2019 21:01Results
The Exchange has sought clarification from Bafna Pharmaceuticals Limited for the quarter ended 30-Jun-2019 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Financial results submitted is not as per format prescribed by SEBI The response of the Company is awaited.
- 10 Aug 2019 15:08PDF · -Results
Bafna Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended June 30, 2019.
- 05 Jun 2019 24:11PDF · -Results
The Exchange had sought clarification from Bafna Pharmaceuticals Limited with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: -1. Financial results not signed by authorized signatory/ies The response of the Company is enclosed.
- 29 May 2019 21:23Results
The Exchange has sought clarification from Bafna Pharmaceuticals Limited with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Financial results not signed by authorized signatory/ies The response of the Company is awaited.
- 27 May 2019 19:44PDF · -Results
Bafna Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended March 31, 2019.
- 08 Feb 2019 19:09PDF · -Results
Bafna Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended December 31, 2018.
- 13 Nov 2018 18:58PDF · -Results
Bafna Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended September 30, 2018.
- 13 Aug 2018 20:37PDF · -Results
Bafna Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended June 30, 2018.
- 04 Jun 2018 16:31PDF · -Results
The Exchange had sought clarification from Bafna Pharmaceuticals Limited with respect to Non-compliance as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: -1. Standalone Reconciliation of profit and loss not submitted -2. The company has not submitted the Statement of Modified Opinion or in case of unmodified opinion(s), a declaration to that effect to the Stock Exchange. The response of the Company is enclosed.
- 29 May 2018 17:44Results
The Exchange has sought clarification from Bafna Pharmaceuticals Limited with respect to Non-compliance as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Standalone Reconciliation of profit and loss not submitted -2. The company has not submitted the Statement of Modified Opinion or in case of unmodified opinion(s), a declaration to that effect to the Stock Exchange. The response of the Company is awaited.
- 28 May 2018 19:49PDF · -Results
Bafna Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended March 31, 2018.
- 12 Feb 2018 18:29PDF · -Results
Bafna Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended 31-Dec-2017.
- 10 Nov 2017 18:39PDF · -Results
Bafna Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended September 30, 2017.
- 14 Aug 2017 08:53PDF · -Results
The Exchange had sought clarification from Bafna Pharmaceuticals Limited with respect to Non-compliance as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.On basis of above the Company was required to clarify the following: -1. Reconciliation of profit and loss not submitted. -2. Financial results not submitted as per Ind-AS format.The response of the Company is enclosed.
- 09 Aug 2017 11:40PDF · -Results
The Exchange has sought clarification from Bafna Pharmaceuticals Limited with respect to Non-compliance as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.On basis of above the Company is required to clarify. -1. Reconciliation of profit and loss not submitted. -2. Financial results not submitted as per Ind-AS format.The response of the Company is awaited.
- 08 Aug 2017 18:58PDF · -Results
Bafna Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended June 30, 2017.
- 27 May 2017 17:02PDF · -Results
Bafna Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended March 31, 2017.
- 04 Feb 2017 14:37PDF · -Results
Bafna Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended December 31, 2016.
- 11 Nov 2016 18:52PDF · -Results
Bafna Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended September 30, 2016.
- 11 Aug 2016 18:41PDF · -Results
Bafna Pharmaceuticals Limited has submitted to the Exchange the standalone financial results along with the Limited Review Report for the period ended June 30, 2016.
- 30 May 2016 19:40PDF · -Results
Bafna Pharmaceuticals Limited has submitted to the Exchange the standalone & consolidated financial results along with the Auditors Report for the period ended March 31, 2016.
- 11 Feb 2016 18:46PDF · -Results
Bafna Pharmaceuticals Limited has submitted to the Exchange the standalone financial results along with the Limited Review Report for the period ended December 31, 2015.
- 06 Nov 2015 18:49PDF · -Results
Bafna Pharmaceuticals Limited has submitted to the exchange the standalone financial results for the period ended 30-Sep-2015.
- 12 Aug 2015 19:23PDF · -Results
Bafna Pharmaceuticals Limited has submitted to the exchange the standalone financial results for the period ended 30-Jun-2015.
- 29 May 2015 19:15PDF · -Results
Bafna Pharmaceuticals Limited has submitted to the exchange the standalone & consolidated financial results for the period ended 31-Mar-2015.
- 12 Feb 2015 20:07PDF · -Results
Bafna Pharmaceuticals Limited has submitted to the exchange the standalone financial results for the period ended 31-Dec-2014.
- 10 Nov 2014 14:35PDF · -Results
Bafna Pharmaceuticals Limited has submitted to the exchange the standalone financial results along with the Limited Review Report for the period ended 30-Sep-2014.
- 07 Aug 2014 20:11PDF · -Results
Bafna Pharmaceuticals Limited has submitted to the exchange the standalone financial results for the period ended 30-Jun-2014.
- 02 Jun 2014 12:47PDF · -Results
Bafna Pharmaceuticals Limited has submitted to the exchange the standalone & consolidated financial results for the period ended 31-Mar-2014.
- 13 Feb 2014 18:31PDF · -Results
Bafna Pharmaceuticals Limited has submitted to the exchange the standalone financial results for the period ended 31-Dec-2013.
- 13 Nov 2013 17:43PDF · -Results
Bafna Pharmaceuticals Limited has submitted to the exchange the standalone financial results for the period ended 30-sep-2013.
- 12 Aug 2013 15:15PDF · -Results
Bafna Pharmaceuticals Limited has submitted to the Exchange the Standalone Financial Results for the period ended June 30,2013.
- 21 May 2013 11:35PDF · -Results
Bafna Pharmaceuticals Limited has submitted to the Exchange the Standalone and Consolidated Financial Results for the period ended March 31,2013.
- 11 Feb 2013 10:54PDF · -Results
Bafna Pharmaceuticals Limited has submitted to the Exchange the Standalone Financial Results for the period ended December 31,2012.
- Results & board-meeting calendar
- Dividend, split, AGM calendar
- Headlines with source and timestamp
- Two-line factual filing summaries